Bora Pharmaceuticals and Celltrion Partners to Expand OSD capabilities in APAC market

by shannon | Apr 5, 2023 | News

Taipei, Taiwan, April 6th, 2023 – Bora Pharmaceuticals Co., Ltd. (“Bora” or “the Company”) and Celltrion Asia Pacific Pte., Ltd. (“Celltrion”), a subsidiary of Celltrion Group Inc, have today announced their partnership to contract manufacture and commercialize a...

Bora expands its CDMO capabilities as it makes landmark acquisition of TWi Pharmaceuticals

by shannon | Oct 3, 2022 | News

Bora establishes a lead position in Taiwan’s CDMO sector. TAIWAN – Fast-growing contract development and manufacturing organization (CDMO), Bora Pharmaceuticals, has completed the acquisition of TWi Pharmaceutical Co.Ltd, a technology-based company...

Bora Pharmaceuticals acquires Eden Biologics CDMO Assets Bora establishes a leadership position in Taiwan’s CDMO sector as it continues to expand into the global CDMO market

by shannon | May 10, 2022 | News

Taiwan-based premier international contract development and manufacturing organization (CDMO) Bora Pharmaceuticals recently announced the establishment of Bora Biologics Co., Ltd., a CDMO platform for biologics. Besides Bora, investors into the new entity include...

Bora Pharmaceuticals to expand operations with $10m investment

by shannon | Apr 20, 2022 | News

TAIWAN – Fast-growing contract development and manufacturing organization (CDMO) BORA Pharmaceuticals, has announced a planned investment of $10 million to expand its Oral Solid Dose capabilities across facilities in Zhunan, Taiwan and Mississauga, Ontario. The...

Bora Pharmaceuticals collaborates with Taishin Holdings to launch CDMO investment and M&A plan

by shannon | Dec 9, 2021 | News

TAIPEI, Taiwan, Dec. 3, 2021 /PRNewswire/ — Bobby Sheng, chairman of Bora Pharmaceuticals (6472.TWO), today announced a partnership with Taishin Healthcare Limited Partnership at the 2021 Biotech Investor Forum, whereby the two parties will jointly invest up to...